SurvivorNet on MSN
A new type of immunotherapy drug showed striking results in hard-to-treat lung cancer, but more data is needed for US patients
A large clinical trial in China (HARMONi-6) found that a new immunotherapy drug, ivonescimab, may help patients with advanced ...
CHICOPEE, Mass. (WWLP) – World Lung Cancer Day has been observed every year on August 1 since 2012 to raise awareness about the risk of the disease. Cooler start to August in western Massachusetts The ...
Thanks to recent therapy advances, the lung cancer mortality rate has declined and survival rates have improved. Many factors influence the likelihood of a lung cancer cure or long-term survival, ...
ImmunityBio (NasdaqGS:IBRX) presented new clinical data on ANKTIVA in advanced non small cell lung cancer and BCG unresponsive non muscle invasive bladder cancer at the 2026 ASCO Annual Meeting. The ...
Lung adenocarcinoma is the most common type of lung cancer diagnosed in the U.S. Just over half of all non-small-cell lung cancers (NSCLCs) are adenocarcinomas. Finding out that you're at risk of lung ...
A Cleveland Clinic study finds Ozempic-style GLP-1 drugs may significantly slow the spread of several obesity-related cancers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results